文献类型：期刊文献

中文题名：半夏泻心汤治疗胃癌研究

英文题名：Review of Banxia Xiexin Decoction in The Treatment of Gastric Cancer

作者：董俊刚[1];刘喜平[1];崔国宁[1];李沛清[1];朱中博[1];张志轩[1]

第一作者：董俊刚

机构：[1]甘肃中医药大学,兰州730000

第一机构：甘肃中医药大学

年份：2021

卷号：27

期号：12

起止页码：1990

中文期刊名：中国中医基础医学杂志

外文期刊名：JOURNAL OF BASIC CHINESE MEDICINE

收录：CSTPCD;;北大核心:【北大核心2020】；CSCD:【CSCD_E2021_2022】；

基金：国家自然科学基金资助项目(81860782)-基于TGF-β1/Smads通路探讨半夏泻心汤干预胃癌外泌体诱发腹膜间皮细胞EMT阻抑胃癌腹膜转移的作用机制;国家自然科学基金资助项目(81860813)-胃癌外泌体激活Shh信号通路诱发MSCs恶性转化及半夏泻心汤干预作用的配伍机制研究。

语种：中文

中文关键词：胃癌;半夏泻心汤;消化道肿瘤

外文关键词：Gastric cancer;Banxia Xiexin decoction;Gastrointestinal cancer

摘要：胃癌是临床最常见的消化道肿瘤,其临床表现多为胃脘灼痛、口苦吞酸、胃部嘈杂等,其病机多为脾虚为本,痰瘀阻滞化热、气机升降失调为标。西医临床治疗多以放化疗为主,病人耐受性不佳。而半夏泻心汤具有辛开苦降、寒热平调、攻补兼施的配伍特点,广泛应用于气机升降失常、寒热错杂、虚实夹杂等病证的治疗中。且半夏泻心汤在胃癌癌前病变的治疗、胃癌微环境的调节、胃癌的转移复发、术后或放化疗后消化道不良反应的改善等方面具有显著疗效。基于此,本文从半夏泻心汤逆转或阻止胃黏膜的癌前病变调节胃癌微环境,抑制胃癌的生长增殖和腹膜转移等方面进行述评,以期为半夏泻心汤防治胃癌的研究提供参考并扩大其临床应用范围。
Gastric cancer is the most common gastrointestinal tumor in clinic,and its clinical manifestations are mostly epigastric burning pain,bitter swallowing of acid in the mouth,stomach discomfort,etc.Its pathogenesis is mainly based on spleen deficiency,phlegm-blood stasis blocking heat,and Qi dysregulation.The clinical treatment of western medicine is mainly chemoradiotherapy with poor patient tolerance.Banxia Xiexin decoction is characterized by the compatibility of"open bitter descent","cold and heat regulating"and"both tonifying and purging".It is widely used in the treatment of diseases and syndromes such as abnormal lifting of Qi activity,mixed cold and heat,and mixed deficiency and excess.Moreover,Banxia Xiexin decoction has significant effects on the treatment of gastric cancer precancerous lesions,the regulation of gastric cancer microenvironment,the metastasis and recurrence of gastric cancer,and the improvement of gastrointestinal adverse reactions after surgery or chemoradiotherapy.Based on this,this paper summarized and analyzed Banxia Xiexin decoction in terms of reversing or preventing precancerous lesions of gastric mucosa,regulating the gastric microenvironment,inhibiting the growth and proliferation of gastric cancer and peritoneal metastasis,in order to provide reference for the research on prevention and treatment of gastric cancer and expand its clinical application scope.